Amit Kumar
Net Worth
Last updated:
What is Amit Kumar net worth?
The estimated net worth of Mr. Amit Kumar is at least $10,733,018 as of 6 Sep 2025. He owns shares worth $1,571,452 as insider, has earned $42,126 from insider trading and has received compensation worth at least $9,119,440 in ABM International Limited and Anixa Biosciences, Inc..
What is the salary of Amit Kumar?
Mr. Amit Kumar salary is $720,870 per year as Chairman, Pres & Chief Executive Officer in Anixa Biosciences, Inc.. He also receives $469,000 as Company Sec. & Compliance Officer in ABM International Limited.
How old is Amit Kumar?
Mr. Amit Kumar is 40 years old, born in 1985.
What stocks does Amit Kumar currently own?
As insider, Mr. Amit Kumar owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Anixa Biosciences, Inc. (ANIX) | Chairman, Pres & Chief Executive Officer | 516,925 | $3.04 | $1,571,452 |
What does Anixa Biosciences, Inc. do?
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Amit Kumar insider trading
Anixa Biosciences, Inc.
Mr. Amit Kumar has made only one insider trade between 2013-2024, according to the Form 4 filled with the SEC. He purchased 25,000 units of ANIX stock worth $60,250 on 7 Jun 2024.
As of 6 Sep 2025 he still owns at least 516,925 units of ANIX stock.
ABM International Limited key executives
ABM International Limited executives and other stock owners filed with the SEC:
- Mr. Amit Kumar (40) Company Sec. & Compliance Officer
- Mr. Virender Kumar Gandhi (83) Chairman & MD
- Mr. Vishwanatha Mahalingam (76) Chief Financial Officer
- Ms. Sangeeta Gandhi B.Com (52) Whole-Time Director